UPDATE: Piper Jaffray Reiterates on Medtronic
November 20, 2013 at 08:40 AM EST
In a report published Wednesday, Piper Jaffray analyst Brooks West reiterated an Overweight rating on Medtronic (NYSE: MDT ) and raised the price target from $58.00 to $68.00. In the report, Piper Jaffray says "Medtronic delivered 3.3% cc revenue growth in F2Q14 (Oct) with revenue of $4.194B topping consensus expectations
